Craving & Decision-Making

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey

About this trial

Craving is the strong desire for something, such as for substances in drug addiction and food or other activities in everyday life. Recent work suggests craving can influence how people make decisions and assign value to choice options available to them, yet the neural mechanisms underlying these interactions between craving and valuation remain unknown. To address this, this study uses cognitive decision-making tasks that measure how much individuals will pay (from a study endowment) to have everyday consumer items or snack foods when they crave something specific (opioids or a specific snack, respectively). First, the study will identify the neural mechanisms for how drug craving (craving for opioids) interacts with valuation for consumer items that have associations with drug use or not in people receiving treatment for opioid use disorder (OUD). This will be evaluated in the activity patterns and interactions among brain regions involved in craving and value assignment during decision-making. Then, the study will examine for parallel mechanisms for how food craving (craving for a specific snack) interacts with valuation for snack food items that have similar features to the craved snack or not in people receiving treatment for OUD and non-psychiatric community control participants.

Eligibility criteria

Qualifiers

At least 18 years of age

Willingness to follow study requirements, as evidenced by an ability to provide written informed consent and read, understand, and complete the study procedures

Minimum of 6th grade reading level

Primary diagnosis of OUD encompassing heroin and/or painkiller use

Disqualifiers

Unable to speak or read English

Active psychosis or mania

Current or past schizophrenia diagnosis

History of intellectual disability or developmental or neurological disorder, seizures or epilepsy, or loss consciousness lasting more than 30 minutes

Trial design

Treatments tested in this trial

  • Audio-visual stimuli (Neutral-Relaxing)
  • Audio-visual stimuli (Drug)
  • Audio-visual stimuli (Non-Food)
  • Audio-visual stimuli (Food)

Treatment groups

160 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Rutgers, The State University of New Jersey

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator